N-acetylcysteine in Intra-amniotic Infection/Inflammation
Conditions
Chorioamnionitis | Infection | Inflammation | Labor, Premature | Preterm Premature Rupture of the Membranes
What is the purpose of this trial?
The aim of the study is to determine if N-acetylcysteine (a potent free radical scavenger) prevents the occurrence of adverse neonatal outcomes in preterm deliveries complicated by infection associated with preterm labor or preterm premature rupture of membranes (PPROM). The working hypothesis is that in pregnancies complicated by intra-amniotic infection or inflammation, N-acetylcysteine protects the fetus by preventing the development, or decreasing the intensity and/or progression of the fetal inflammatory syndrome.
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Female
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- October 2006
- Last Updated:
- July 18, 2012
- Study HIC#:
- 0603001228
Clinicaltrials.gov ID: NCT00397735


